Response Genetics, Inc. to Serve as the Molecular Screening Center for ALCHEMIST
August 18, 2014 13:15 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Second Quarter 2014 Financial Results
August 14, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 14, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Second Quarter 2014 Financial Results and Host Conference Call on August 14, 2014
August 07, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 7, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics Secures $12.0 Million Credit Facility
August 05, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, and SWK Funding LLC...
Response Genetics Launches New Test for Cancer Immunotherapy Drug Development
June 16, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, June 16, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...
FDA-Cleared, Medicare-Reimbursed, ResponseDX: Tissue of Origin(TM) Test Added to National Institute of Health's (NIH) Genetic Testing Registry
June 12, 2014 10:07 ET
|
Response Genetics, Inc.
LOS ANGELES, June 12, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...
Response Genetics extiende la distribución de ResponseDX(R) Cartera de productos en los mercados internacionales
May 14, 2014 12:10 ET
|
Response Genetics, Inc.
LOS ÁNGELES, 2014-05-14 18:10 CEST (GLOBE NEWSWIRE) --
Response Genetics, Inc. (Nasdaq:RGDX), una compañía enfocada en el desarrollo y la comercialización de pruebas genéticas moleculares que ayudan...
Response Genetics Expands Distribution of ResponseDX(R) Product Portfolio Into International Markets
May 14, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, May 14, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help guide cancer therapy...
Response Genetics, Inc. Announces First Quarter 2014 Financial Results
May 08, 2014 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, May 8, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response...
Response Genetics, Inc. to Release First Quarter 2014 Financial Results and Host Conference Call on May 8, 2014
May 01, 2014 16:05 ET
|
Response Genetics, Inc.
LOS ANGELES, May 1, 2014 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response...